Gainers
- NeuroMetrix, Inc. (NASDAQ:NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.
- Grab Holdings Limited (NASDAQ:GRAB) gained 26.1% to $3.1902 after reporting Q1 results.
- SIGA Technologies, Inc. (NASDAQ:SIGA) shares gained 19.9% to $8.86 after the company announced the FDA approved the intravenous formulation of TPOXX for the treatment of smallpox.
- Zealand Pharma A/S (NASDAQ:ZEAL) jumped 17.3% to $13.73 after the company announced the results from its phase 3 trial of Dasiglucagon in pediatric patients with congenital hyperinsulinism met the primary endpoint with statistical significance.
- Snow Lake Resources Ltd. (NASDAQ:LITM) gained 16.2% to $3.80 after the company reported results from its first drill tests from the Grass River Pegmatite dyke. The company also said its exploration permits have been extended by the Province of Manitoba for 3 years.
- Indaptus Therapeutics, Inc. (NASDAQ:INDP) rose 15.2% to $2.8801. The U.S. Food and Drug Administration (FDA) has announced clearance to Indaptus Therapeutics’ Investigational New Drug (IND) application for a Phase 1 clinical trial of its drug candidate Decoy20 in patients with advanced solid tumors where currently approved therapies have failed.
- Immunome, Inc. (NASDAQ:IMNM) surged 15.2% to $3.2722 after the company published data demonstrating its COVID-19 antibody cocktail IMM-BCP-01 cleared the omicron variant of SARS-CoV-2 when tested in vivo in hamsters.
- Kodiak Sciences Inc. (NASDAQ:KOD) gained 14.7% to $6.88 after company director Felix Baker reported the purchase of 456,690 shares at an average price of $5.91 per share in a Form 4 filing on Wednesday.
- Cellectis S.A. (NASDAQ:CLLS) jumped 13.5% to $3.71.
- Novan, Inc. (NASDAQ:NOVN) gained 13.5% to $2.95. Novan will present Berdazimer Gel, 10.3% (SB206) clinical data at Annual Meeting of the Society for Investigative Dermatology.
- Emergent BioSolutions Inc. (NYSE:EBS) rose 12.5% to $31.88.
- GDS Holdings Limited (NASDAQ:GDS) climbed 12.2% to $30.47. GDS Holdings posted a Q1 net loss of $58.9 million.
- Sweetgreen, Inc. (NYSE:SG) jumped 12.1% to $21.50.
- Humanigen, Inc. (NASDAQ:HGEN) surged 11.8% to $2.27. Humanigen recently posted Q1 loss of $0.32 per share.
- Chinook Therapeutics, Inc. (NASDAQ:KDNY) gained 11.8% to $14.08 as the company announced updated interim results from the Phase 1/2 study of BION-1301 in IgA nephropathy (IgAN).
- Bill.com Holdings, Inc. (NASDAQ:BILL) rose 11.4% to $113.17.
- Blend Labs, Inc. (NYSE:BLND) gained 11.4% to $3.69.
- Synopsys, Inc. (NASDAQ:SNPS) jumped 11% to $302.47 after the company reported better-than-expected Q2 results. The company also issued Q3 and FY22 EPS and sales guidance above analyst estimates.
- Unity Software Inc. (NYSE:U) gained 10.5% to $41.39.
- Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) gained 10.2% to $5.51.
- Sprout Social, Inc. (NASDAQ:SPT) gained 9.9% to $45.54.
- Datadog, Inc. (NASDAQ:DDOG) rose 9.7% to $96.62.
